Inogen | 销售和管理费用





销售和管理费用 更改 日
Abbott USD 3.13B 125M 2025-12
AngioDynamics USD 35.99M 14K 2025-02
AtriCure USD 78.23M 158K 2025-09
Baxter International USD 708M 10M 2025-09
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Chart Industries USD 136M 9.3M 2025-09
Cooper Companies USD 419.2M 12M 2025-09
Dexcom USD 331.4M 3.4M 2025-09
Edwards Lifesciences USD 514.6M 12.6M 2025-09
Globus Medical USD 313.6M 9.98M 2025-09
Inogen USD 43.77M 510K 2024-06
Insulet USD 315.2M 61.9M 2025-09
Masimo USD 116.4M 20.5M 2025-09
Medtronic 2.97B 159M 2025-09
Orthofix International USD 112.21M 1.1M 2024-09
Philips EUR 1.31B 127M 2025-12
ResMed USD 278.4M 19.2M 2025-12
Steris USD 352.3M 2.6M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 94.52M 1.47M 2025-09
Teleflex USD 281.76M 66.68M 2025-09
X T L Biopharmaceuticals USD 706K 50K 2024-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12


Inogen 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.